Trademark: 85583345
Word
MOLECULARHEALTH
Status Date
Friday, November 19, 2021
Registration Number
4710227
Registration Date
Tuesday, March 31, 2015
Filing Date
Thursday, March 29, 2012
Published for Opposition
Tuesday, July 1, 2014
Cancellation Date
Friday, November 19, 2021
35 Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
42 Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
44 Providing an online database featuring medical, pharmaceutical and genomic information for medical diagnostic or treatment purposes; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; medical consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others
Color is not claimed as a feature of the mark.
"MOLECULAR HEALTH"
The mark consists of circle within a circle and an arrow within the inner circle and the word "MOLECULARHEALTH" to the right of the image.
MOLECULAR HEALTH
Nov 19, 2021
Cancelled Sec. 8 (6-Yr)
Mar 31, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 31, 2015
Registered-Principal Register
Feb 26, 2015
1(B) Basis Deleted; Proceed To Registration
Feb 26, 2015
Notice Of Allowance Cancelled
Feb 24, 2015
Teas Delete 1(B) Basis Received
Aug 28, 2014
Noa Mailed - Sou Required From Applicant
Aug 26, 2014
Noa E-Mailed - Sou Required From Applicant
Aug 20, 2014
Assignment Of Ownership Not Updated Automatically
Jul 2, 2014
Notice Of Publication
Jul 1, 2014
Official Gazette Publication Confirmation E-Mailed
Jul 1, 2014
Published For Opposition
Jun 11, 2014
Notification Of Notice Of Publication E-Mailed
May 23, 2014
Law Office Publication Review Completed
May 22, 2014
Approved For Pub - Principal Register
May 15, 2014
Examiner's Amendment Entered
May 15, 2014
Notification Of Examiners Amendment E-Mailed
May 15, 2014
Examiners Amendment E-Mailed
May 15, 2014
Examiners Amendment -Written
Apr 24, 2014
Notification Of Priority Action E-Mailed
Apr 24, 2014
Priority Action E-Mailed
Apr 24, 2014
Priority Action Written
Mar 20, 2014
Teas/Email Correspondence Entered
Mar 20, 2014
Correspondence Received In Law Office
Mar 14, 2014
Teas Response To Suspension Inquiry Received
Sep 25, 2013
Notification Of Inquiry As To Suspension E-Mailed
Sep 25, 2013
Inquiry To Suspension E-Mailed
Sep 25, 2013
Suspension Inquiry Written
Sep 19, 2013
Suspension Checked ¿ To Attorney For Action
Mar 14, 2013
Notification Of Letter Of Suspension E-Mailed
Mar 14, 2013
Letter Of Suspension E-Mailed
Mar 14, 2013
Suspension Letter Written
Mar 7, 2013
Examiner's Amendment Entered
Mar 7, 2013
Notification Of Examiners Amendment E-Mailed
Mar 7, 2013
Examiners Amendment E-Mailed
Mar 7, 2013
Examiners Amendment -Written
Jan 31, 2013
Teas/Email Correspondence Entered
Jan 31, 2013
Correspondence Received In Law Office
Jan 24, 2013
Assigned To Lie
Jan 22, 2013
Teas Response To Office Action Received
Jan 22, 2013
Teas Change Of Correspondence Received
Jul 22, 2012
Notification Of Non-Final Action E-Mailed
Jul 22, 2012
Non-Final Action E-Mailed
Jul 22, 2012
Non-Final Action Written
Jul 10, 2012
Assigned To Examiner
Apr 5, 2012
Notice Of Design Search Code Mailed
Apr 4, 2012
New Application Office Supplied Data Entered In Tram
Apr 2, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
